This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Athenex, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Laura Beth Pitzonka: Innovator in Pharmaceutical Research
Introduction
Laura Beth Pitzonka, an accomplished inventor based in Blasdell, NY, has made significant contributions to the field of pharmaceuticals. With a patent to her name, Laura has demonstrated her commitment to advancing medical science and improving treatment options for various disorders.
Latest Patents
Laura's notable patent is titled "Acetamido-phenyltetrazole derivatives and methods of using the same." This patent involves compounds of Formula (IA) and encompasses their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for preparation. The compounds are particularly useful in treating disorders where P-glycoprotein and/or cytochrome P450 (CYP3A4) is modulated, including cancers that have developed multi-drug resistance. Her innovative work addresses critical needs in the medical community.
Career Highlights
Currently, Laura Beth Pitzonka is associated with Athenex, Inc., a company that focuses on the development of innovative therapies for cancer. Through her work at Athenex, Laura has been able to apply her creative prowess to significant scientific challenges, showcasing her expertise in pharmaceutical innovation.
Collaborations
Laura has collaborated with talented colleagues, including Sameer Urgaonkar and Ahmed M Said. These collaborations reflect a strong commitment to teamwork and innovation in the pharmaceutical research arena, allowing them to push the boundaries of what is possible in treating complex medical conditions.
Conclusion
In conclusion, Laura Beth Pitzonka is a remarkable inventor whose work in pharmaceutical research is paving the way for new treatments. With her patent on acetamido-phenyltetrazole derivatives, she contributes significantly to our understanding and management of critical health issues. Her collaborations at Athenex and beyond exemplify the spirit of innovation necessary to drive the pharmaceutical industry forward.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
